UK NHS Disclosure Plans Slammed

2 January 1995

The new code of practice proposed by the UK Department of Health on access of information held by health authorities, trusts and other National Health Service bodies falls far short of the "open government" code of practice which came into force this April (Marketletters November 28 & December 5), according to the Campaign for Freedom of Information. The proposed code would allow such bodies to keep secret information that would have to be disclosed if held by the DoH, and produce "bizarre" decisions for which no logical justification can be found, it says.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight